Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)

Montefiore Medical Center, The Bronx

Northwell Health - Monter Cancer Center, New Hyde Park

Georgetown University Hospital, Washington D.C.

Duke University Medical Center, Durham

Greenville Health System Cancer Institute, Greenville

Emory University - Winship Cancer Institute, Atlanta

Hematology Oncology Associates of the Tr, Port Saint Lucie

University of Alabama At Birmingham Comprehensive Cancer Center, Birmingham

Ohio State University - Wexner Medical Center, Columbus

Signal Point Clinical Research Center, Middletown

University of Michigan Health System, Ann Arbor

Washington University School of Medicine, St Louis

Mary Crowley Cancer Research Ctr, Dallas

Baylor Scott & White Health, Temple

Md Anderson Cancer Center, Houston

South Texas Accelerated Research Therapeutics, San Antonio

Cedars-Sinai Medical Center, West Hollywood

Yale Cancer Center, New Haven

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack

The Finsen Centre National Hospital, Copenhagen